1
|
Petran EM, Periferakis A, Troumpata L, Periferakis AT, Scheau AE, Badarau IA, Periferakis K, Caruntu A, Savulescu-Fiedler I, Sima RM, Calina D, Constantin C, Neagu M, Caruntu C, Scheau C. Capsaicin: Emerging Pharmacological and Therapeutic Insights. Curr Issues Mol Biol 2024; 46:7895-7943. [PMID: 39194685 DOI: 10.3390/cimb46080468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2024] [Revised: 07/19/2024] [Accepted: 07/22/2024] [Indexed: 08/29/2024] Open
Abstract
Capsaicin, the most prominent pungent compound of chilli peppers, has been used in traditional medicine systems for centuries; it already has a number of established clinical and industrial applications. Capsaicin is known to act through the TRPV1 receptor, which exists in various tissues; capsaicin is hepatically metabolised, having a half-life correlated with the method of application. Research on various applications of capsaicin in different formulations is still ongoing. Thus, local capsaicin applications have a pronounced anti-inflammatory effect, while systemic applications have a multitude of different effects because their increased lipophilic character ensures their augmented bioavailability. Furthermore, various teams have documented capsaicin's anti-cancer effects, proven both in vivo and in vitro designs. A notable constraint in the therapeutic effects of capsaicin is its increased toxicity, especially in sensitive tissues. Regarding the traditional applications of capsaicin, apart from all the effects recorded as medicinal effects, the application of capsaicin in acupuncture points has been demonstrated to be effective and the combination of acupuncture and capsaicin warrants further research. Finally, capsaicin has demonstrated antimicrobial effects, which can supplement its anti-inflammatory and anti-carcinogenic actions.
Collapse
Affiliation(s)
- Elena Madalina Petran
- Department of Biochemistry, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Toxicology, Grigore Alexandrescu Emergency Children's Hospital, 011743 Bucharest, Romania
| | - Argyrios Periferakis
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Akadimia of Ancient Greek and Traditional Chinese Medicine, 16675 Athens, Greece
- Elkyda, Research & Education Centre of Charismatheia, 17675 Athens, Greece
| | - Lamprini Troumpata
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
| | - Aristodemos-Theodoros Periferakis
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Elkyda, Research & Education Centre of Charismatheia, 17675 Athens, Greece
| | - Andreea-Elena Scheau
- Department of Radiology and Medical Imaging, Fundeni Clinical Institute, 022328 Bucharest, Romania
| | - Ioana Anca Badarau
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
| | - Konstantinos Periferakis
- Akadimia of Ancient Greek and Traditional Chinese Medicine, 16675 Athens, Greece
- Pan-Hellenic Organization of Educational Programs (P.O.E.P), 17236 Athens, Greece
| | - Ana Caruntu
- Department of Oral and Maxillofacial Surgery, The "Carol Davila" Central Military Emergency Hospital, 010825 Bucharest, Romania
- Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, "Titu Maiorescu" University, 031593 Bucharest, Romania
| | - Ilinca Savulescu-Fiedler
- Department of Internal Medicine, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Internal Medicine and Cardiology, Coltea Clinical Hospital, 030167 Bucharest, Romania
| | - Romina-Marina Sima
- Department of Obstetrics and Gynecology, The "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania
- The "Bucur" Maternity, "Saint John" Hospital, 040294 Bucharest, Romania
| | - Daniela Calina
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania
| | - Carolina Constantin
- Immunology Department, Victor Babes National Institute of Pathology, 050096 Bucharest, Romania
- Department of Pathology, Colentina University Hospital, 020125 Bucharest, Romania
| | - Monica Neagu
- Immunology Department, Victor Babes National Institute of Pathology, 050096 Bucharest, Romania
- Department of Pathology, Colentina University Hospital, 020125 Bucharest, Romania
- Faculty of Biology, University of Bucharest, 76201 Bucharest, Romania
| | - Constantin Caruntu
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Dermatology, "Prof. N.C. Paulescu" National Institute of Diabetes, Nutrition and Metabolic Diseases, 011233 Bucharest, Romania
| | - Cristian Scheau
- Department of Physiology, The "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Radiology and Medical Imaging, "Foisor" Clinical Hospital of Orthopaedics, Traumatology and Osteoarticular TB, 021382 Bucharest, Romania
| |
Collapse
|
9
|
Andrè E, Campi B, Materazzi S, Trevisani M, Amadesi S, Massi D, Creminon C, Vaksman N, Nassini R, Civelli M, Baraldi PG, Poole DP, Bunnett NW, Geppetti P, Patacchini R. Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest 2008; 118:2574-82. [PMID: 18568077 PMCID: PMC2430498 DOI: 10.1172/jci34886] [Citation(s) in RCA: 193] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2007] [Accepted: 04/23/2008] [Indexed: 01/21/2023] Open
Abstract
Cigarette smoke (CS) inhalation causes an early inflammatory response in rodent airways by stimulating capsaicin-sensitive sensory neurons that express transient receptor potential cation channel, subfamily V, member 1 (TRPV1) through an unknown mechanism that does not involve TRPV1. We hypothesized that 2 alpha,beta-unsaturated aldehydes present in CS, crotonaldehyde and acrolein, induce neurogenic inflammation by stimulating TRPA1, an excitatory ion channel coexpressed with TRPV1 on capsaicin-sensitive nociceptors. We found that CS aqueous extract (CSE), crotonaldehyde, and acrolein mobilized Ca2+ in cultured guinea pig jugular ganglia neurons and promoted contraction of isolated guinea pig bronchi. These responses were abolished by a TRPA1-selective antagonist and by the aldehyde scavenger glutathione but not by the TRPV1 antagonist capsazepine or by ROS scavengers. Treatment with CSE or aldehydes increased Ca2+ influx in TRPA1-transfected cells, but not in control HEK293 cells, and promoted neuropeptide release from isolated guinea pig airway tissue. Furthermore, the effect of CSE and aldehydes on Ca2+ influx in dorsal root ganglion neurons was abolished in TRPA1-deficient mice. These data identify alpha,beta-unsaturated aldehydes as the main causative agents in CS that via TRPA1 stimulation mediate airway neurogenic inflammation and suggest a role for TRPA1 in the pathogenesis of CS-induced diseases.
Collapse
Affiliation(s)
- Eunice Andrè
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Barbara Campi
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Serena Materazzi
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Marcello Trevisani
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Silvia Amadesi
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Daniela Massi
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Christophe Creminon
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Natalya Vaksman
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Romina Nassini
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Maurizio Civelli
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Pier Giovanni Baraldi
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Daniel P. Poole
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Nigel W. Bunnett
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Pierangelo Geppetti
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| | - Riccardo Patacchini
- Center of Excellence for the Study of Inflammation, University of Ferrara, Ferrara, Italy.
Clinical Pharmacology Unit, Department of Critical Care Medicine and Surgery, University of Florence, Florence, Italy.
Departments of Physiology and Surgery, UCSF, San Francisco, California, USA.
Department of Human Pathology and Oncology, University of Florence, Florence, Italy.
CEA, Institut de Biologie et Technologies de Saclay (iBiTec-S), Service de pharmacologie et d'immuno analyse (SPI), Gif sur Yvette, France.
Pharmacology Department, Chiesi Pharmaceuticals, Parma, Italy.
Department of Pharmaceutical Chemistry, University of Ferrara, Ferrara, Italy
| |
Collapse
|